Leydig cell desensitization by increased cyclic-AMP inactivation.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000728:Androgens / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism / Q000494:pharmacology*; D007985:Leydig Cells / Q000201:enzymology / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000494:pharmacology; D008297:Male; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism
D000728:Androgens; D006063:Chorionic Gonadotropin; D011956:Receptors, Cell Surface; D003994:Bucladesine; D007986:Luteinizing Hormone; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D015056:1-Methyl-3-isobutylxanthine